Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
We employ our advanced, specialised process to create targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology employs molecular simulations to explore a wide array of proteins, capturing their dynamic states both individually and within complexes. Through ensemble virtual screening, we address conformational mobility, uncovering binding sites within functional regions and remote allosteric locations. This thorough exploration ensures no potential mechanism of action is overlooked, aiming to discover novel therapeutic targets and lead compounds across an extensive spectrum of biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
Q9BXB5
UPID:
OSB10_HUMAN
Alternative names:
-
Alternative UPACC:
Q9BXB5; B4E212; Q9BTU5
Background:
Oxysterol-binding protein-related protein 10 (ORP10) plays a crucial role in lipid transport between the endoplasmic reticulum and the plasma membrane. It specifically exchanges phosphatidylserine with phosphatidylinositol 4-phosphate, facilitating the delivery of phosphatidylserine to the plasma membrane. ORP10 also influences lipid biosynthesis negatively and regulates APOB secretion from hepatocytes, while binding to cholesterol, acidic phospholipids, and 25-hydroxycholesterol.
Therapeutic significance:
Understanding the role of Oxysterol-binding protein-related protein 10 could open doors to potential therapeutic strategies.